These 2 Biotech Stocks Are Set To Split The $15 Billion Hepatitis C Market
December 12, 2014 at 11:44 AM EST
A recent report by Morgan Stanley predicts a greater than 40 percent growth in the Hepatitis C (HCV) market in 2015. Projections ...